Manuva, I think the words of any EXCO team member, including the CEO, is usually only as good as the team under them and the information they provide. I have done my research, and the skill set of the team doing the prepatory work behind LBT's FDA approval is nothing short of first class, I would hazard to say market leading across the world.
If you are not accepting that LBT's product is unique call the company and ask some tough questions. Again, I am comfortable that LBT's product is quite unique and there will be strong appetite in the market.
Ann: LBT to Present at Melbourne Investor Forum, page-36
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
-0.001(3.23%) |
Mkt cap ! $24.27M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.6¢ | 1.5¢ | $2.364K | 150.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 66666 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 1366332 | 4 |
View Market Depth
| Last trade - 10.07am 26/08/2024 (20 minute delay) ? |
| LBT (ASX) Chart |